CMS seeks insurers to share ACA successes for June forum

Insurers finding success in offering coverage on the Affordable Care Act’s insurance exchanges are being asked to share what they’ve learned at a CMS forum June 9.

The invitation came in the form of a blog post by Health Insurance Marketplace CEO Kevin Counihan, who alluded to recent news about insurers, including UnitedHealth and Humana, choosing to leave exchanges in 2017 after blaming decreased profits on their marketplace business.

“Everyone expected that it would take time for companies to adjust their pricing and practices to what is effectively a new market,” Counihan wrote. “And it’s also no surprise that the pace of adaptation has varied across issuers. Some companies have struggled so far in this new market, while others are already succeeding in providing affordable care through a sustainable business model.”

Counihan went on to ask for those successful plans “to present their insights and innovation at a forum,” along with promising other presentations focused on engaging with marketplace customers, contracting with providers and using population data to inform care coordination.

“The success stories come from all across the country and from diverse types of insurers and markets. But one theme that’s consistent is that success in the marketplace requires a different approach to providing care than was required for success in the old individual market, “ Counihan wrote.

Among the organizations expected to discuss their techniques are Aetna, CareSource, SelectHealth, UPMC, the Society of Actuaries and Blue Cross Blue Shield plans from Florida, Massachusetts and New Jersey.

A time for the presentations wasn’t mentioned, but it will be streamed at hhs.gov/live

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.